nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—Propofol—epilepsy syndrome	0.424	1	CrCtD
Fospropofol—GABRD—epilepsy syndrome	0.0512	0.24	CbGaD
Fospropofol—GABRG2—epilepsy syndrome	0.0388	0.182	CbGaD
Fospropofol—GABRA5—epilepsy syndrome	0.0312	0.146	CbGaD
Fospropofol—GABRB3—epilepsy syndrome	0.0312	0.146	CbGaD
Fospropofol—GABRB2—epilepsy syndrome	0.0273	0.128	CbGaD
Fospropofol—GABRA1—epilepsy syndrome	0.0268	0.126	CbGaD
Fospropofol—ALB—epilepsy syndrome	0.00699	0.0327	CbGaD
Fospropofol—GABRA6—Amobarbital—epilepsy syndrome	0.00693	0.0274	CbGbCtD
Fospropofol—GABRA4—Amobarbital—epilepsy syndrome	0.00675	0.0267	CbGbCtD
Fospropofol—GABRB2—Clonazepam—epilepsy syndrome	0.00634	0.0251	CbGbCtD
Fospropofol—GABRB2—Clobazam—epilepsy syndrome	0.00608	0.024	CbGbCtD
Fospropofol—GABRD—Midazolam—epilepsy syndrome	0.00578	0.0229	CbGbCtD
Fospropofol—GABRG1—Midazolam—epilepsy syndrome	0.00578	0.0229	CbGbCtD
Fospropofol—GABRA3—Clonazepam—epilepsy syndrome	0.00577	0.0228	CbGbCtD
Fospropofol—GABRA6—Primidone—epilepsy syndrome	0.00576	0.0228	CbGbCtD
Fospropofol—GABRA4—Primidone—epilepsy syndrome	0.00562	0.0222	CbGbCtD
Fospropofol—GABRG3—Midazolam—epilepsy syndrome	0.0056	0.0222	CbGbCtD
Fospropofol—GABRD—Diazepam—epilepsy syndrome	0.00556	0.022	CbGbCtD
Fospropofol—GABRG1—Diazepam—epilepsy syndrome	0.00556	0.022	CbGbCtD
Fospropofol—GABRB1—Midazolam—epilepsy syndrome	0.00544	0.0215	CbGbCtD
Fospropofol—GABRG3—Diazepam—epilepsy syndrome	0.00539	0.0213	CbGbCtD
Fospropofol—GABRA5—Amobarbital—epilepsy syndrome	0.00533	0.0211	CbGbCtD
Fospropofol—GABRG2—Clonazepam—epilepsy syndrome	0.0053	0.021	CbGbCtD
Fospropofol—GABRB1—Diazepam—epilepsy syndrome	0.00523	0.0207	CbGbCtD
Fospropofol—GABRA3—Amobarbital—epilepsy syndrome	0.00514	0.0203	CbGbCtD
Fospropofol—GABRG2—Clobazam—epilepsy syndrome	0.00508	0.0201	CbGbCtD
Fospropofol—GABRA2—Amobarbital—epilepsy syndrome	0.00496	0.0196	CbGbCtD
Fospropofol—GABRA6—Midazolam—epilepsy syndrome	0.00487	0.0193	CbGbCtD
Fospropofol—GABRA4—Midazolam—epilepsy syndrome	0.00474	0.0188	CbGbCtD
Fospropofol—GABRB2—Primidone—epilepsy syndrome	0.0047	0.0186	CbGbCtD
Fospropofol—GABRA5—Primidone—epilepsy syndrome	0.00444	0.0175	CbGbCtD
Fospropofol—GABRA1—Clonazepam—epilepsy syndrome	0.00441	0.0174	CbGbCtD
Fospropofol—GABRA3—Primidone—epilepsy syndrome	0.00428	0.0169	CbGbCtD
Fospropofol—GABRA1—Clobazam—epilepsy syndrome	0.00422	0.0167	CbGbCtD
Fospropofol—GABRB2—Propofol—epilepsy syndrome	0.00421	0.0167	CbGbCtD
Fospropofol—GABRA2—Primidone—epilepsy syndrome	0.00413	0.0163	CbGbCtD
Fospropofol—GABRB3—Propofol—epilepsy syndrome	0.00397	0.0157	CbGbCtD
Fospropofol—GABRB2—Midazolam—epilepsy syndrome	0.00397	0.0157	CbGbCtD
Fospropofol—GABRG2—Primidone—epilepsy syndrome	0.00393	0.0156	CbGbCtD
Fospropofol—GABRA1—Amobarbital—epilepsy syndrome	0.00393	0.0155	CbGbCtD
Fospropofol—GABRB2—Diazepam—epilepsy syndrome	0.00382	0.0151	CbGbCtD
Fospropofol—GABRA5—Midazolam—epilepsy syndrome	0.00375	0.0148	CbGbCtD
Fospropofol—GABRB3—Midazolam—epilepsy syndrome	0.00375	0.0148	CbGbCtD
Fospropofol—GABRA2—Propofol—epilepsy syndrome	0.0037	0.0146	CbGbCtD
Fospropofol—GABRA3—Midazolam—epilepsy syndrome	0.00361	0.0143	CbGbCtD
Fospropofol—GABRA5—Diazepam—epilepsy syndrome	0.0036	0.0142	CbGbCtD
Fospropofol—GABRB3—Diazepam—epilepsy syndrome	0.0036	0.0142	CbGbCtD
Fospropofol—GABRG2—Propofol—epilepsy syndrome	0.00352	0.0139	CbGbCtD
Fospropofol—GABRA2—Midazolam—epilepsy syndrome	0.00349	0.0138	CbGbCtD
Fospropofol—GABRA3—Diazepam—epilepsy syndrome	0.00347	0.0137	CbGbCtD
Fospropofol—GABRA2—Diazepam—epilepsy syndrome	0.00335	0.0133	CbGbCtD
Fospropofol—GABRG2—Midazolam—epilepsy syndrome	0.00332	0.0131	CbGbCtD
Fospropofol—ALB—Oxcarbazepine—epilepsy syndrome	0.00331	0.0131	CbGbCtD
Fospropofol—GABRA1—Primidone—epilepsy syndrome	0.00327	0.0129	CbGbCtD
Fospropofol—GABRG2—Diazepam—epilepsy syndrome	0.00319	0.0126	CbGbCtD
Fospropofol—GABRA1—Propofol—epilepsy syndrome	0.00293	0.0116	CbGbCtD
Fospropofol—ALB—Fosphenytoin—epilepsy syndrome	0.00289	0.0114	CbGbCtD
Fospropofol—GABRA1—Phenobarbital—epilepsy syndrome	0.0028	0.0111	CbGbCtD
Fospropofol—GABRA1—Midazolam—epilepsy syndrome	0.00276	0.0109	CbGbCtD
Fospropofol—GABRB2—Topiramate—epilepsy syndrome	0.00271	0.0107	CbGbCtD
Fospropofol—GABRA1—Diazepam—epilepsy syndrome	0.00265	0.0105	CbGbCtD
Fospropofol—ALB—Clonazepam—epilepsy syndrome	0.00261	0.0103	CbGbCtD
Fospropofol—GABRG2—Topiramate—epilepsy syndrome	0.00227	0.00898	CbGbCtD
Fospropofol—ALB—Rufinamide—epilepsy syndrome	0.00213	0.00843	CbGbCtD
Fospropofol—GABRA1—Topiramate—epilepsy syndrome	0.00189	0.00747	CbGbCtD
Fospropofol—ALB—Phenytoin—epilepsy syndrome	0.00186	0.00737	CbGbCtD
Fospropofol—ALB—Propofol—epilepsy syndrome	0.00174	0.00687	CbGbCtD
Fospropofol—ALB—Diazepam—epilepsy syndrome	0.00157	0.00623	CbGbCtD
Fospropofol—GABRG1—ganglion—epilepsy syndrome	0.00064	0.0332	CbGeAlD
Fospropofol—GABRA6—hindbrain—epilepsy syndrome	0.000483	0.025	CbGeAlD
Fospropofol—Propofol—SCN4A—epilepsy syndrome	0.000442	0.226	CrCbGaD
Fospropofol—GABRA2—ganglion—epilepsy syndrome	0.000428	0.0222	CbGeAlD
Fospropofol—ALPL—medulla oblongata—epilepsy syndrome	0.000411	0.0214	CbGeAlD
Fospropofol—ALPL—midbrain—epilepsy syndrome	0.000376	0.0195	CbGeAlD
Fospropofol—GABRB2—hindbrain—epilepsy syndrome	0.000355	0.0184	CbGeAlD
Fospropofol—GABRA2—hindbrain—epilepsy syndrome	0.000325	0.0168	CbGeAlD
Fospropofol—GABRA1—hindbrain—epilepsy syndrome	0.000314	0.0163	CbGeAlD
Fospropofol—Propofol—GABRG2—epilepsy syndrome	0.000312	0.159	CrCbGaD
Fospropofol—ALPL—cerebellum—epilepsy syndrome	0.000291	0.0151	CbGeAlD
Fospropofol—Propofol—SCN2A—epilepsy syndrome	0.000285	0.145	CrCbGaD
Fospropofol—GABRD—forebrain—epilepsy syndrome	0.000279	0.0145	CbGeAlD
Fospropofol—GABRA6—brainstem—epilepsy syndrome	0.000277	0.0144	CbGeAlD
Fospropofol—GABRG1—forebrain—epilepsy syndrome	0.000269	0.0139	CbGeAlD
Fospropofol—GABRA5—forebrain—epilepsy syndrome	0.000259	0.0134	CbGeAlD
Fospropofol—GABRD—telencephalon—epilepsy syndrome	0.000257	0.0133	CbGeAlD
Fospropofol—Propofol—GABRB3—epilepsy syndrome	0.000251	0.128	CrCbGaD
Fospropofol—GABRG1—telencephalon—epilepsy syndrome	0.000247	0.0128	CbGeAlD
Fospropofol—GABRA6—telencephalon—epilepsy syndrome	0.000246	0.0127	CbGeAlD
Fospropofol—GABRB1—telencephalon—epilepsy syndrome	0.000239	0.0124	CbGeAlD
Fospropofol—GABRA5—telencephalon—epilepsy syndrome	0.000238	0.0124	CbGeAlD
Fospropofol—ALPL—brain—epilepsy syndrome	0.000236	0.0123	CbGeAlD
Fospropofol—GABRA4—forebrain—epilepsy syndrome	0.000235	0.0122	CbGeAlD
Fospropofol—Propofol—GABRB2—epilepsy syndrome	0.00022	0.112	CrCbGaD
Fospropofol—GABRA4—telencephalon—epilepsy syndrome	0.000216	0.0112	CbGeAlD
Fospropofol—Propofol—GABRA1—epilepsy syndrome	0.000216	0.11	CrCbGaD
Fospropofol—GABRB2—brainstem—epilepsy syndrome	0.000204	0.0106	CbGeAlD
Fospropofol—GABRD—medulla oblongata—epilepsy syndrome	0.000202	0.0105	CbGeAlD
Fospropofol—GABRG2—forebrain—epilepsy syndrome	0.000197	0.0102	CbGeAlD
Fospropofol—GABRB2—forebrain—epilepsy syndrome	0.000197	0.0102	CbGeAlD
Fospropofol—GABRG1—medulla oblongata—epilepsy syndrome	0.000194	0.0101	CbGeAlD
Fospropofol—GABRG3—head—epilepsy syndrome	0.000193	0.01	CbGeAlD
Fospropofol—GABRB1—medulla oblongata—epilepsy syndrome	0.000188	0.00976	CbGeAlD
Fospropofol—GABRA2—brainstem—epilepsy syndrome	0.000186	0.00966	CbGeAlD
Fospropofol—GABRD—midbrain—epilepsy syndrome	0.000184	0.00956	CbGeAlD
Fospropofol—GABRG3—nervous system—epilepsy syndrome	0.000183	0.00949	CbGeAlD
Fospropofol—GABRB2—telencephalon—epilepsy syndrome	0.000181	0.00938	CbGeAlD
Fospropofol—GABRG2—telencephalon—epilepsy syndrome	0.000181	0.00938	CbGeAlD
Fospropofol—GABRA1—brainstem—epilepsy syndrome	0.00018	0.00933	CbGeAlD
Fospropofol—GABRA2—forebrain—epilepsy syndrome	0.00018	0.00932	CbGeAlD
Fospropofol—GABRG1—midbrain—epilepsy syndrome	0.000177	0.0092	CbGeAlD
Fospropofol—Hypotension—Amobarbital—epilepsy syndrome	0.000177	0.00454	CcSEcCtD
Fospropofol—GABRG3—central nervous system—epilepsy syndrome	0.000176	0.00914	CbGeAlD
Fospropofol—GABRA1—forebrain—epilepsy syndrome	0.000174	0.00901	CbGeAlD
Fospropofol—GABRG1—spinal cord—epilepsy syndrome	0.000173	0.00898	CbGeAlD
Fospropofol—GABRB1—midbrain—epilepsy syndrome	0.000172	0.00892	CbGeAlD
Fospropofol—Apnoea—Gabapentin—epilepsy syndrome	0.000172	0.00441	CcSEcCtD
Fospropofol—GABRB1—spinal cord—epilepsy syndrome	0.000168	0.00871	CbGeAlD
Fospropofol—GABRA2—telencephalon—epilepsy syndrome	0.000165	0.00857	CbGeAlD
Fospropofol—GABRD—head—epilepsy syndrome	0.00016	0.00829	CbGeAlD
Fospropofol—GABRA1—telencephalon—epilepsy syndrome	0.00016	0.00828	CbGeAlD
Fospropofol—Ventricular tachycardia—Pregabalin—epilepsy syndrome	0.000159	0.00407	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Primidone—epilepsy syndrome	0.000158	0.00404	CcSEcCtD
Fospropofol—GABRG1—head—epilepsy syndrome	0.000154	0.00798	CbGeAlD
Fospropofol—GABRA6—head—epilepsy syndrome	0.000153	0.00793	CbGeAlD
Fospropofol—GABRD—nervous system—epilepsy syndrome	0.000151	0.00786	CbGeAlD
Fospropofol—GABRB3—forebrain—epilepsy syndrome	0.000151	0.00783	CbGeAlD
Fospropofol—GABRB1—head—epilepsy syndrome	0.000149	0.00774	CbGeAlD
Fospropofol—GABRA5—head—epilepsy syndrome	0.000148	0.0077	CbGeAlD
Fospropofol—GABRD—central nervous system—epilepsy syndrome	0.000146	0.00757	CbGeAlD
Fospropofol—GABRG1—nervous system—epilepsy syndrome	0.000146	0.00757	CbGeAlD
Fospropofol—GABRA6—nervous system—epilepsy syndrome	0.000145	0.00752	CbGeAlD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Rufinamide—epilepsy syndrome	0.000145	0.00371	CcSEcCtD
Fospropofol—Paraesthesia—Trimethadione—epilepsy syndrome	0.000144	0.0037	CcSEcCtD
Fospropofol—GABRD—cerebellum—epilepsy syndrome	0.000143	0.0074	CbGeAlD
Fospropofol—GABRG2—medulla oblongata—epilepsy syndrome	0.000142	0.00737	CbGeAlD
Fospropofol—GABRB2—medulla oblongata—epilepsy syndrome	0.000142	0.00737	CbGeAlD
Fospropofol—Hepatic failure—Valproic Acid—epilepsy syndrome	0.000142	0.00364	CcSEcCtD
Fospropofol—GABRB1—nervous system—epilepsy syndrome	0.000141	0.00734	CbGeAlD
Fospropofol—GABRA5—nervous system—epilepsy syndrome	0.000141	0.0073	CbGeAlD
Fospropofol—GABRG1—central nervous system—epilepsy syndrome	0.00014	0.00728	CbGeAlD
Fospropofol—GABRG3—brain—epilepsy syndrome	0.00014	0.00725	CbGeAlD
Fospropofol—GABRA6—central nervous system—epilepsy syndrome	0.00014	0.00724	CbGeAlD
Fospropofol—GABRB3—telencephalon—epilepsy syndrome	0.000139	0.0072	CbGeAlD
Fospropofol—GABRA3—head—epilepsy syndrome	0.000138	0.00716	CbGeAlD
Fospropofol—GABRG1—cerebellum—epilepsy syndrome	0.000137	0.00712	CbGeAlD
Fospropofol—Nervous system disorder—Rufinamide—epilepsy syndrome	0.000137	0.00351	CcSEcCtD
Fospropofol—GABRA6—cerebellum—epilepsy syndrome	0.000136	0.00708	CbGeAlD
Fospropofol—Cough—Clobazam—epilepsy syndrome	0.000136	0.00349	CcSEcCtD
Fospropofol—GABRB1—central nervous system—epilepsy syndrome	0.000136	0.00706	CbGeAlD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Lacosamide—epilepsy syndrome	0.000136	0.00348	CcSEcCtD
Fospropofol—Skin disorder—Rufinamide—epilepsy syndrome	0.000136	0.00348	CcSEcCtD
Fospropofol—GABRA5—central nervous system—epilepsy syndrome	0.000135	0.00703	CbGeAlD
Fospropofol—GABRA4—head—epilepsy syndrome	0.000135	0.00698	CbGeAlD
Fospropofol—GABRB1—cerebellum—epilepsy syndrome	0.000133	0.0069	CbGeAlD
Fospropofol—Hypotension—Phenobarbital—epilepsy syndrome	0.000133	0.00341	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Clobazam—epilepsy syndrome	0.000132	0.00338	CcSEcCtD
Fospropofol—GABRA3—nervous system—epilepsy syndrome	0.000131	0.00679	CbGeAlD
Fospropofol—Mediastinal disorder—Midazolam—epilepsy syndrome	0.000131	0.00335	CcSEcCtD
Fospropofol—GABRG2—midbrain—epilepsy syndrome	0.00013	0.00674	CbGeAlD
Fospropofol—GABRB2—midbrain—epilepsy syndrome	0.00013	0.00674	CbGeAlD
Fospropofol—Mediastinal disorder—Levetiracetam—epilepsy syndrome	0.000129	0.00331	CcSEcCtD
Fospropofol—Nervous system disorder—Lacosamide—epilepsy syndrome	0.000129	0.0033	CcSEcCtD
Fospropofol—GABRA4—nervous system—epilepsy syndrome	0.000128	0.00662	CbGeAlD
Fospropofol—Skin disorder—Lacosamide—epilepsy syndrome	0.000127	0.00327	CcSEcCtD
Fospropofol—GABRB2—spinal cord—epilepsy syndrome	0.000127	0.00657	CbGeAlD
Fospropofol—GABRG2—spinal cord—epilepsy syndrome	0.000127	0.00657	CbGeAlD
Fospropofol—GABRA3—central nervous system—epilepsy syndrome	0.000126	0.00654	CbGeAlD
Fospropofol—GABRA1—medulla oblongata—epilepsy syndrome	0.000125	0.00651	CbGeAlD
Fospropofol—Nervous system disorder—Clobazam—epilepsy syndrome	0.000125	0.0032	CcSEcCtD
Fospropofol—Skin disorder—Clobazam—epilepsy syndrome	0.000124	0.00317	CcSEcCtD
Fospropofol—GABRA4—central nervous system—epilepsy syndrome	0.000123	0.00637	CbGeAlD
Fospropofol—Pain—Phenobarbital—epilepsy syndrome	0.000122	0.00312	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Rufinamide—epilepsy syndrome	0.000121	0.00309	CcSEcCtD
Fospropofol—Vomiting—Amobarbital—epilepsy syndrome	0.000121	0.00309	CcSEcCtD
Fospropofol—Angiopathy—Diazepam—epilepsy syndrome	0.00012	0.00309	CcSEcCtD
Fospropofol—GABRA4—cerebellum—epilepsy syndrome	0.00012	0.00623	CbGeAlD
Fospropofol—Hypotension—Clobazam—epilepsy syndrome	0.000119	0.00305	CcSEcCtD
Fospropofol—Headache—Amobarbital—epilepsy syndrome	0.000119	0.00305	CcSEcCtD
Fospropofol—Paraesthesia—Lacosamide—epilepsy syndrome	0.000118	0.00302	CcSEcCtD
Fospropofol—Hepatic failure—Gabapentin—epilepsy syndrome	0.000118	0.00302	CcSEcCtD
Fospropofol—Vomiting—Primidone—epilepsy syndrome	0.000116	0.00298	CcSEcCtD
Fospropofol—GABRD—brain—epilepsy syndrome	0.000116	0.00601	CbGeAlD
Fospropofol—GABRA1—midbrain—epilepsy syndrome	0.000115	0.00595	CbGeAlD
Fospropofol—Headache—Primidone—epilepsy syndrome	0.000114	0.00293	CcSEcCtD
Fospropofol—Pruritus—Trimethadione—epilepsy syndrome	0.000114	0.00292	CcSEcCtD
Fospropofol—Mediastinal disorder—Zonisamide—epilepsy syndrome	0.000113	0.00291	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Lacosamide—epilepsy syndrome	0.000113	0.0029	CcSEcCtD
Fospropofol—Cough—Propofol—epilepsy syndrome	0.000113	0.00289	CcSEcCtD
Fospropofol—Nausea—Amobarbital—epilepsy syndrome	0.000113	0.00289	CcSEcCtD
Fospropofol—GABRG2—head—epilepsy syndrome	0.000113	0.00584	CbGeAlD
Fospropofol—GABRB2—head—epilepsy syndrome	0.000113	0.00584	CbGeAlD
Fospropofol—GABRA1—spinal cord—epilepsy syndrome	0.000112	0.0058	CbGeAlD
Fospropofol—GABRG1—brain—epilepsy syndrome	0.000111	0.00578	CbGeAlD
Fospropofol—GABRA6—brain—epilepsy syndrome	0.000111	0.00575	CbGeAlD
Fospropofol—Cough—Midazolam—epilepsy syndrome	0.00011	0.00283	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Clobazam—epilepsy syndrome	0.00011	0.00282	CcSEcCtD
Fospropofol—GABRB3—medulla oblongata—epilepsy syndrome	0.000109	0.00566	CbGeAlD
Fospropofol—Cough—Levetiracetam—epilepsy syndrome	0.000109	0.00279	CcSEcCtD
Fospropofol—Angiopathy—Oxcarbazepine—epilepsy syndrome	0.000109	0.00279	CcSEcCtD
Fospropofol—Nausea—Primidone—epilepsy syndrome	0.000109	0.00278	CcSEcCtD
Fospropofol—GABRB1—brain—epilepsy syndrome	0.000108	0.00561	CbGeAlD
Fospropofol—GABRA5—brain—epilepsy syndrome	0.000107	0.00558	CbGeAlD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Midazolam—epilepsy syndrome	0.000107	0.00274	CcSEcCtD
Fospropofol—GABRG2—nervous system—epilepsy syndrome	0.000107	0.00554	CbGeAlD
Fospropofol—GABRB2—nervous system—epilepsy syndrome	0.000107	0.00554	CbGeAlD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Levetiracetam—epilepsy syndrome	0.000106	0.00271	CcSEcCtD
Fospropofol—Cough—Fosphenytoin—epilepsy syndrome	0.000105	0.00269	CcSEcCtD
Fospropofol—Angiopathy—Carbamazepine—epilepsy syndrome	0.000104	0.00267	CcSEcCtD
Fospropofol—Mediastinal disorder—Carbamazepine—epilepsy syndrome	0.000104	0.00266	CcSEcCtD
Fospropofol—GABRA2—head—epilepsy syndrome	0.000103	0.00534	CbGeAlD
Fospropofol—GABRB2—central nervous system—epilepsy syndrome	0.000103	0.00533	CbGeAlD
Fospropofol—GABRG2—central nervous system—epilepsy syndrome	0.000103	0.00533	CbGeAlD
Fospropofol—Cough—Vigabatrin—epilepsy syndrome	0.000102	0.00263	CcSEcCtD
Fospropofol—Vomiting—Trimethadione—epilepsy syndrome	0.000102	0.00262	CcSEcCtD
Fospropofol—Paraesthesia—Acetazolamide—epilepsy syndrome	0.000102	0.00261	CcSEcCtD
Fospropofol—Propofol—CYP2C19—epilepsy syndrome	0.000101	0.0518	CrCbGaD
Fospropofol—Nervous system disorder—Midazolam—epilepsy syndrome	0.000101	0.00259	CcSEcCtD
Fospropofol—Cough—Diazepam—epilepsy syndrome	0.000101	0.00259	CcSEcCtD
Fospropofol—Angiopathy—Lamotrigine—epilepsy syndrome	0.000101	0.00258	CcSEcCtD
Fospropofol—Headache—Trimethadione—epilepsy syndrome	0.000101	0.00258	CcSEcCtD
Fospropofol—GABRB2—cerebellum—epilepsy syndrome	0.0001	0.00521	CbGeAlD
Fospropofol—GABRG2—cerebellum—epilepsy syndrome	0.0001	0.00521	CbGeAlD
Fospropofol—Skin disorder—Midazolam—epilepsy syndrome	0.0001	0.00257	CcSEcCtD
Fospropofol—Mediastinal disorder—Lamotrigine—epilepsy syndrome	0.0001	0.00257	CcSEcCtD
Fospropofol—GABRA3—brain—epilepsy syndrome	0.0001	0.00519	CbGeAlD
Fospropofol—Nervous system disorder—Levetiracetam—epilepsy syndrome	9.99e-05	0.00256	CcSEcCtD
Fospropofol—GABRB3—midbrain—epilepsy syndrome	9.97e-05	0.00517	CbGeAlD
Fospropofol—GABRA1—head—epilepsy syndrome	9.94e-05	0.00516	CbGeAlD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Vigabatrin—epilepsy syndrome	9.93e-05	0.00254	CcSEcCtD
Fospropofol—Hepatic failure—Topiramate—epilepsy syndrome	9.9e-05	0.00254	CcSEcCtD
Fospropofol—Skin disorder—Levetiracetam—epilepsy syndrome	9.89e-05	0.00254	CcSEcCtD
Fospropofol—Pruritus—Rufinamide—epilepsy syndrome	9.89e-05	0.00253	CcSEcCtD
Fospropofol—Hypotension—Propofol—epilepsy syndrome	9.85e-05	0.00253	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Acetazolamide—epilepsy syndrome	9.8e-05	0.00251	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Diazepam—epilepsy syndrome	9.77e-05	0.00251	CcSEcCtD
Fospropofol—Cough—Felbamate—epilepsy syndrome	9.76e-05	0.0025	CcSEcCtD
Fospropofol—GABRA4—brain—epilepsy syndrome	9.75e-05	0.00506	CbGeAlD
Fospropofol—GABRA2—nervous system—epilepsy syndrome	9.75e-05	0.00506	CbGeAlD
Fospropofol—GABRB3—spinal cord—epilepsy syndrome	9.73e-05	0.00505	CbGeAlD
Fospropofol—Hypotension—Midazolam—epilepsy syndrome	9.64e-05	0.00247	CcSEcCtD
Fospropofol—Cough—Zonisamide—epilepsy syndrome	9.56e-05	0.00245	CcSEcCtD
Fospropofol—Nausea—Trimethadione—epilepsy syndrome	9.55e-05	0.00245	CcSEcCtD
Fospropofol—Paraesthesia—Propofol—epilepsy syndrome	9.47e-05	0.00243	CcSEcCtD
Fospropofol—GABRA1—nervous system—epilepsy syndrome	9.42e-05	0.00489	CbGeAlD
Fospropofol—Nervous system disorder—Vigabatrin—epilepsy syndrome	9.4e-05	0.00241	CcSEcCtD
Fospropofol—GABRA2—central nervous system—epilepsy syndrome	9.39e-05	0.00487	CbGeAlD
Fospropofol—Skin disorder—Vigabatrin—epilepsy syndrome	9.31e-05	0.00239	CcSEcCtD
Fospropofol—Pruritus—Lacosamide—epilepsy syndrome	9.28e-05	0.00238	CcSEcCtD
Fospropofol—Paraesthesia—Midazolam—epilepsy syndrome	9.26e-05	0.00237	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Zonisamide—epilepsy syndrome	9.26e-05	0.00237	CcSEcCtD
Fospropofol—Nervous system disorder—Diazepam—epilepsy syndrome	9.25e-05	0.00237	CcSEcCtD
Fospropofol—Cough—Clonazepam—epilepsy syndrome	9.21e-05	0.00236	CcSEcCtD
Fospropofol—Hypotension—Fosphenytoin—epilepsy syndrome	9.19e-05	0.00235	CcSEcCtD
Fospropofol—GABRA2—cerebellum—epilepsy syndrome	9.18e-05	0.00476	CbGeAlD
Fospropofol—Skin disorder—Diazepam—epilepsy syndrome	9.16e-05	0.00235	CcSEcCtD
Fospropofol—Cough—Phenytoin—epilepsy syndrome	9.15e-05	0.00235	CcSEcCtD
Fospropofol—Paraesthesia—Levetiracetam—epilepsy syndrome	9.15e-05	0.00234	CcSEcCtD
Fospropofol—Cough—Oxcarbazepine—epilepsy syndrome	9.1e-05	0.00233	CcSEcCtD
Fospropofol—GABRA1—central nervous system—epilepsy syndrome	9.07e-05	0.00471	CbGeAlD
Fospropofol—Vomiting—Phenobarbital—epilepsy syndrome	9.05e-05	0.00232	CcSEcCtD
Fospropofol—Pain—Propofol—epilepsy syndrome	9.02e-05	0.00231	CcSEcCtD
Fospropofol—Pruritus—Clobazam—epilepsy syndrome	9.01e-05	0.00231	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Clonazepam—epilepsy syndrome	8.92e-05	0.00229	CcSEcCtD
Fospropofol—Headache—Phenobarbital—epilepsy syndrome	8.92e-05	0.00229	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Midazolam—epilepsy syndrome	8.9e-05	0.00228	CcSEcCtD
Fospropofol—Vomiting—Rufinamide—epilepsy syndrome	8.88e-05	0.00228	CcSEcCtD
Fospropofol—GABRA1—cerebellum—epilepsy syndrome	8.87e-05	0.0046	CbGeAlD
Fospropofol—Paraesthesia—Fosphenytoin—epilepsy syndrome	8.83e-05	0.00226	CcSEcCtD
Fospropofol—Pain—Midazolam—epilepsy syndrome	8.82e-05	0.00226	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Oxcarbazepine—epilepsy syndrome	8.82e-05	0.00226	CcSEcCtD
Fospropofol—Hypotension—Diazepam—epilepsy syndrome	8.81e-05	0.00226	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Levetiracetam—epilepsy syndrome	8.79e-05	0.00225	CcSEcCtD
Fospropofol—Nervous system disorder—Zonisamide—epilepsy syndrome	8.76e-05	0.00225	CcSEcCtD
Fospropofol—Headache—Rufinamide—epilepsy syndrome	8.75e-05	0.00224	CcSEcCtD
Fospropofol—Pain—Levetiracetam—epilepsy syndrome	8.71e-05	0.00223	CcSEcCtD
Fospropofol—Skin disorder—Zonisamide—epilepsy syndrome	8.68e-05	0.00223	CcSEcCtD
Fospropofol—GABRB3—head—epilepsy syndrome	8.64e-05	0.00449	CbGeAlD
Fospropofol—Paraesthesia—Vigabatrin—epilepsy syndrome	8.6e-05	0.00221	CcSEcCtD
Fospropofol—Hypotension—Felbamate—epilepsy syndrome	8.53e-05	0.00219	CcSEcCtD
Fospropofol—Paraesthesia—Diazepam—epilepsy syndrome	8.47e-05	0.00217	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Carbamazepine—epilepsy syndrome	8.46e-05	0.00217	CcSEcCtD
Fospropofol—Nausea—Phenobarbital—epilepsy syndrome	8.46e-05	0.00217	CcSEcCtD
Fospropofol—Nervous system disorder—Clonazepam—epilepsy syndrome	8.45e-05	0.00217	CcSEcCtD
Fospropofol—Cough—Lamotrigine—epilepsy syndrome	8.44e-05	0.00216	CcSEcCtD
Fospropofol—Nervous system disorder—Phenytoin—epilepsy syndrome	8.39e-05	0.00215	CcSEcCtD
Fospropofol—Skin disorder—Clonazepam—epilepsy syndrome	8.37e-05	0.00214	CcSEcCtD
Fospropofol—Hypotension—Zonisamide—epilepsy syndrome	8.35e-05	0.00214	CcSEcCtD
Fospropofol—Nervous system disorder—Oxcarbazepine—epilepsy syndrome	8.35e-05	0.00214	CcSEcCtD
Fospropofol—Vomiting—Lacosamide—epilepsy syndrome	8.34e-05	0.00214	CcSEcCtD
Fospropofol—Nausea—Rufinamide—epilepsy syndrome	8.3e-05	0.00213	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Vigabatrin—epilepsy syndrome	8.27e-05	0.00212	CcSEcCtD
Fospropofol—Skin disorder—Oxcarbazepine—epilepsy syndrome	8.27e-05	0.00212	CcSEcCtD
Fospropofol—Headache—Lacosamide—epilepsy syndrome	8.22e-05	0.00211	CcSEcCtD
Fospropofol—Paraesthesia—Felbamate—epilepsy syndrome	8.2e-05	0.0021	CcSEcCtD
Fospropofol—GABRB3—nervous system—epilepsy syndrome	8.2e-05	0.00425	CbGeAlD
Fospropofol—Pain—Vigabatrin—epilepsy syndrome	8.19e-05	0.0021	CcSEcCtD
Fospropofol—GABRG2—brain—epilepsy syndrome	8.16e-05	0.00423	CbGeAlD
Fospropofol—GABRB2—brain—epilepsy syndrome	8.16e-05	0.00423	CbGeAlD
Fospropofol—Gastrointestinal disorder—Diazepam—epilepsy syndrome	8.14e-05	0.00209	CcSEcCtD
Fospropofol—Vomiting—Clobazam—epilepsy syndrome	8.1e-05	0.00208	CcSEcCtD
Fospropofol—Pain—Diazepam—epilepsy syndrome	8.07e-05	0.00207	CcSEcCtD
Fospropofol—Hypotension—Clonazepam—epilepsy syndrome	8.05e-05	0.00206	CcSEcCtD
Fospropofol—Paraesthesia—Zonisamide—epilepsy syndrome	8.03e-05	0.00206	CcSEcCtD
Fospropofol—Angiopathy—Valproic Acid—epilepsy syndrome	8.01e-05	0.00205	CcSEcCtD
Fospropofol—Nervous system disorder—Carbamazepine—epilepsy syndrome	8.01e-05	0.00205	CcSEcCtD
Fospropofol—Hypotension—Phenytoin—epilepsy syndrome	7.99e-05	0.00205	CcSEcCtD
Fospropofol—Headache—Clobazam—epilepsy syndrome	7.98e-05	0.00205	CcSEcCtD
Fospropofol—Mediastinal disorder—Valproic Acid—epilepsy syndrome	7.96e-05	0.00204	CcSEcCtD
Fospropofol—Hypotension—Oxcarbazepine—epilepsy syndrome	7.95e-05	0.00204	CcSEcCtD
Fospropofol—Skin disorder—Carbamazepine—epilepsy syndrome	7.93e-05	0.00203	CcSEcCtD
Fospropofol—GABRB3—central nervous system—epilepsy syndrome	7.89e-05	0.00409	CbGeAlD
Fospropofol—Pain—Felbamate—epilepsy syndrome	7.81e-05	0.002	CcSEcCtD
Fospropofol—Nausea—Lacosamide—epilepsy syndrome	7.79e-05	0.002	CcSEcCtD
Fospropofol—Nervous system disorder—Lamotrigine—epilepsy syndrome	7.74e-05	0.00198	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	7.72e-05	0.00198	CcSEcCtD
Fospropofol—GABRB3—cerebellum—epilepsy syndrome	7.71e-05	0.004	CbGeAlD
Fospropofol—Paraesthesia—Phenytoin—epilepsy syndrome	7.68e-05	0.00197	CcSEcCtD
Fospropofol—Hypotension—Carbamazepine—epilepsy syndrome	7.63e-05	0.00196	CcSEcCtD
Fospropofol—Nausea—Clobazam—epilepsy syndrome	7.56e-05	0.00194	CcSEcCtD
Fospropofol—Propofol—CYP2D6—epilepsy syndrome	7.52e-05	0.0384	CrCbGaD
Fospropofol—Pruritus—Propofol—epilepsy syndrome	7.46e-05	0.00191	CcSEcCtD
Fospropofol—GABRA2—brain—epilepsy syndrome	7.45e-05	0.00387	CbGeAlD
Fospropofol—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	7.44e-05	0.00191	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	7.39e-05	0.00189	CcSEcCtD
Fospropofol—Pain—Clonazepam—epilepsy syndrome	7.37e-05	0.00189	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	7.35e-05	0.00188	CcSEcCtD
Fospropofol—Paraesthesia—Carbamazepine—epilepsy syndrome	7.33e-05	0.00188	CcSEcCtD
Fospropofol—Pruritus—Midazolam—epilepsy syndrome	7.3e-05	0.00187	CcSEcCtD
Fospropofol—Pain—Oxcarbazepine—epilepsy syndrome	7.28e-05	0.00187	CcSEcCtD
Fospropofol—Angiopathy—Pregabalin—epilepsy syndrome	7.24e-05	0.00186	CcSEcCtD
Fospropofol—Vomiting—Acetazolamide—epilepsy syndrome	7.22e-05	0.00185	CcSEcCtD
Fospropofol—Pruritus—Levetiracetam—epilepsy syndrome	7.21e-05	0.00185	CcSEcCtD
Fospropofol—GABRA1—brain—epilepsy syndrome	7.2e-05	0.00374	CbGeAlD
Fospropofol—Mediastinal disorder—Pregabalin—epilepsy syndrome	7.19e-05	0.00184	CcSEcCtD
Fospropofol—Headache—Acetazolamide—epilepsy syndrome	7.11e-05	0.00182	CcSEcCtD
Fospropofol—Paraesthesia—Lamotrigine—epilepsy syndrome	7.09e-05	0.00182	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	7.05e-05	0.00181	CcSEcCtD
Fospropofol—Pain—Carbamazepine—epilepsy syndrome	6.98e-05	0.00179	CcSEcCtD
Fospropofol—Pruritus—Fosphenytoin—epilepsy syndrome	6.95e-05	0.00178	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	6.81e-05	0.00175	CcSEcCtD
Fospropofol—Pruritus—Vigabatrin—epilepsy syndrome	6.78e-05	0.00174	CcSEcCtD
Fospropofol—Pain—Lamotrigine—epilepsy syndrome	6.75e-05	0.00173	CcSEcCtD
Fospropofol—Nausea—Acetazolamide—epilepsy syndrome	6.74e-05	0.00173	CcSEcCtD
Fospropofol—ALB—brain—epilepsy syndrome	6.74e-05	0.0035	CbGeAlD
Fospropofol—Cough—Valproic Acid—epilepsy syndrome	6.71e-05	0.00172	CcSEcCtD
Fospropofol—Vomiting—Propofol—epilepsy syndrome	6.7e-05	0.00172	CcSEcCtD
Fospropofol—Pruritus—Diazepam—epilepsy syndrome	6.67e-05	0.00171	CcSEcCtD
Fospropofol—Headache—Propofol—epilepsy syndrome	6.6e-05	0.00169	CcSEcCtD
Fospropofol—Mediastinal disorder—Gabapentin—epilepsy syndrome	6.6e-05	0.00169	CcSEcCtD
Fospropofol—Vomiting—Midazolam—epilepsy syndrome	6.56e-05	0.00168	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	6.5e-05	0.00167	CcSEcCtD
Fospropofol—Vomiting—Levetiracetam—epilepsy syndrome	6.48e-05	0.00166	CcSEcCtD
Fospropofol—Headache—Midazolam—epilepsy syndrome	6.46e-05	0.00166	CcSEcCtD
Fospropofol—Pruritus—Felbamate—epilepsy syndrome	6.46e-05	0.00166	CcSEcCtD
Fospropofol—Headache—Levetiracetam—epilepsy syndrome	6.38e-05	0.00164	CcSEcCtD
Fospropofol—Pruritus—Zonisamide—epilepsy syndrome	6.32e-05	0.00162	CcSEcCtD
Fospropofol—GABRB3—brain—epilepsy syndrome	6.26e-05	0.00325	CbGeAlD
Fospropofol—Nausea—Propofol—epilepsy syndrome	6.26e-05	0.00161	CcSEcCtD
Fospropofol—Vomiting—Fosphenytoin—epilepsy syndrome	6.25e-05	0.0016	CcSEcCtD
Fospropofol—Headache—Fosphenytoin—epilepsy syndrome	6.16e-05	0.00158	CcSEcCtD
Fospropofol—Nervous system disorder—Valproic Acid—epilepsy syndrome	6.15e-05	0.00158	CcSEcCtD
Fospropofol—Nausea—Midazolam—epilepsy syndrome	6.13e-05	0.00157	CcSEcCtD
Fospropofol—Pruritus—Clonazepam—epilepsy syndrome	6.09e-05	0.00156	CcSEcCtD
Fospropofol—Vomiting—Vigabatrin—epilepsy syndrome	6.09e-05	0.00156	CcSEcCtD
Fospropofol—Skin disorder—Valproic Acid—epilepsy syndrome	6.09e-05	0.00156	CcSEcCtD
Fospropofol—Cough—Pregabalin—epilepsy syndrome	6.06e-05	0.00155	CcSEcCtD
Fospropofol—Pruritus—Phenytoin—epilepsy syndrome	6.05e-05	0.00155	CcSEcCtD
Fospropofol—Nausea—Levetiracetam—epilepsy syndrome	6.05e-05	0.00155	CcSEcCtD
Fospropofol—Pruritus—Oxcarbazepine—epilepsy syndrome	6.02e-05	0.00154	CcSEcCtD
Fospropofol—Headache—Vigabatrin—epilepsy syndrome	6e-05	0.00154	CcSEcCtD
Fospropofol—Vomiting—Diazepam—epilepsy syndrome	6e-05	0.00154	CcSEcCtD
Fospropofol—Headache—Diazepam—epilepsy syndrome	5.91e-05	0.00152	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.87e-05	0.00151	CcSEcCtD
Fospropofol—Hypotension—Valproic Acid—epilepsy syndrome	5.86e-05	0.0015	CcSEcCtD
Fospropofol—Nausea—Fosphenytoin—epilepsy syndrome	5.84e-05	0.0015	CcSEcCtD
Fospropofol—Vomiting—Felbamate—epilepsy syndrome	5.81e-05	0.00149	CcSEcCtD
Fospropofol—Pruritus—Carbamazepine—epilepsy syndrome	5.78e-05	0.00148	CcSEcCtD
Fospropofol—Headache—Felbamate—epilepsy syndrome	5.72e-05	0.00147	CcSEcCtD
Fospropofol—Nausea—Vigabatrin—epilepsy syndrome	5.69e-05	0.00146	CcSEcCtD
Fospropofol—Vomiting—Zonisamide—epilepsy syndrome	5.68e-05	0.00146	CcSEcCtD
Fospropofol—Paraesthesia—Valproic Acid—epilepsy syndrome	5.63e-05	0.00144	CcSEcCtD
Fospropofol—Propofol—ALB—epilepsy syndrome	5.63e-05	0.0287	CrCbGaD
Fospropofol—Nausea—Diazepam—epilepsy syndrome	5.6e-05	0.00144	CcSEcCtD
Fospropofol—Headache—Zonisamide—epilepsy syndrome	5.6e-05	0.00144	CcSEcCtD
Fospropofol—Angiopathy—Topiramate—epilepsy syndrome	5.59e-05	0.00143	CcSEcCtD
Fospropofol—Pruritus—Lamotrigine—epilepsy syndrome	5.58e-05	0.00143	CcSEcCtD
Fospropofol—Nervous system disorder—Pregabalin—epilepsy syndrome	5.56e-05	0.00143	CcSEcCtD
Fospropofol—Cough—Gabapentin—epilepsy syndrome	5.56e-05	0.00143	CcSEcCtD
Fospropofol—Mediastinal disorder—Topiramate—epilepsy syndrome	5.55e-05	0.00142	CcSEcCtD
Fospropofol—Skin disorder—Pregabalin—epilepsy syndrome	5.51e-05	0.00141	CcSEcCtD
Fospropofol—Vomiting—Clonazepam—epilepsy syndrome	5.48e-05	0.0014	CcSEcCtD
Fospropofol—Vomiting—Phenytoin—epilepsy syndrome	5.44e-05	0.00139	CcSEcCtD
Fospropofol—Nausea—Felbamate—epilepsy syndrome	5.42e-05	0.00139	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	5.41e-05	0.00139	CcSEcCtD
Fospropofol—Vomiting—Oxcarbazepine—epilepsy syndrome	5.41e-05	0.00139	CcSEcCtD
Fospropofol—Headache—Clonazepam—epilepsy syndrome	5.4e-05	0.00138	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.39e-05	0.00138	CcSEcCtD
Fospropofol—Pain—Valproic Acid—epilepsy syndrome	5.36e-05	0.00137	CcSEcCtD
Fospropofol—Headache—Phenytoin—epilepsy syndrome	5.36e-05	0.00137	CcSEcCtD
Fospropofol—Headache—Oxcarbazepine—epilepsy syndrome	5.33e-05	0.00137	CcSEcCtD
Fospropofol—Nausea—Zonisamide—epilepsy syndrome	5.31e-05	0.00136	CcSEcCtD
Fospropofol—Hypotension—Pregabalin—epilepsy syndrome	5.3e-05	0.00136	CcSEcCtD
Fospropofol—Vomiting—Carbamazepine—epilepsy syndrome	5.19e-05	0.00133	CcSEcCtD
Fospropofol—Nausea—Clonazepam—epilepsy syndrome	5.12e-05	0.00131	CcSEcCtD
Fospropofol—Headache—Carbamazepine—epilepsy syndrome	5.12e-05	0.00131	CcSEcCtD
Fospropofol—Nervous system disorder—Gabapentin—epilepsy syndrome	5.1e-05	0.00131	CcSEcCtD
Fospropofol—Paraesthesia—Pregabalin—epilepsy syndrome	5.09e-05	0.00131	CcSEcCtD
Fospropofol—Nausea—Phenytoin—epilepsy syndrome	5.08e-05	0.0013	CcSEcCtD
Fospropofol—Nausea—Oxcarbazepine—epilepsy syndrome	5.06e-05	0.0013	CcSEcCtD
Fospropofol—Skin disorder—Gabapentin—epilepsy syndrome	5.05e-05	0.00129	CcSEcCtD
Fospropofol—Vomiting—Lamotrigine—epilepsy syndrome	5.02e-05	0.00129	CcSEcCtD
Fospropofol—Headache—Lamotrigine—epilepsy syndrome	4.94e-05	0.00127	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.9e-05	0.00125	CcSEcCtD
Fospropofol—Hypotension—Gabapentin—epilepsy syndrome	4.86e-05	0.00125	CcSEcCtD
Fospropofol—Nausea—Carbamazepine—epilepsy syndrome	4.85e-05	0.00124	CcSEcCtD
Fospropofol—Pain—Pregabalin—epilepsy syndrome	4.85e-05	0.00124	CcSEcCtD
Fospropofol—Nausea—Lamotrigine—epilepsy syndrome	4.69e-05	0.0012	CcSEcCtD
Fospropofol—Cough—Topiramate—epilepsy syndrome	4.68e-05	0.0012	CcSEcCtD
Fospropofol—Paraesthesia—Gabapentin—epilepsy syndrome	4.67e-05	0.0012	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.53e-05	0.00116	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	4.49e-05	0.00115	CcSEcCtD
Fospropofol—Pain—Gabapentin—epilepsy syndrome	4.45e-05	0.00114	CcSEcCtD
Fospropofol—Pruritus—Valproic Acid—epilepsy syndrome	4.44e-05	0.00114	CcSEcCtD
Fospropofol—Nervous system disorder—Topiramate—epilepsy syndrome	4.29e-05	0.0011	CcSEcCtD
Fospropofol—Skin disorder—Topiramate—epilepsy syndrome	4.25e-05	0.00109	CcSEcCtD
Fospropofol—Hypotension—Topiramate—epilepsy syndrome	4.09e-05	0.00105	CcSEcCtD
Fospropofol—Pruritus—Pregabalin—epilepsy syndrome	4.01e-05	0.00103	CcSEcCtD
Fospropofol—Vomiting—Valproic Acid—epilepsy syndrome	3.99e-05	0.00102	CcSEcCtD
Fospropofol—Headache—Valproic Acid—epilepsy syndrome	3.93e-05	0.00101	CcSEcCtD
Fospropofol—Paraesthesia—Topiramate—epilepsy syndrome	3.93e-05	0.00101	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.78e-05	0.000968	CcSEcCtD
Fospropofol—Pain—Topiramate—epilepsy syndrome	3.74e-05	0.000959	CcSEcCtD
Fospropofol—Nausea—Valproic Acid—epilepsy syndrome	3.73e-05	0.000955	CcSEcCtD
Fospropofol—Pruritus—Gabapentin—epilepsy syndrome	3.68e-05	0.000943	CcSEcCtD
Fospropofol—Vomiting—Pregabalin—epilepsy syndrome	3.61e-05	0.000924	CcSEcCtD
Fospropofol—Headache—Pregabalin—epilepsy syndrome	3.55e-05	0.000911	CcSEcCtD
Fospropofol—Nausea—Pregabalin—epilepsy syndrome	3.37e-05	0.000863	CcSEcCtD
Fospropofol—Vomiting—Gabapentin—epilepsy syndrome	3.31e-05	0.000847	CcSEcCtD
Fospropofol—Headache—Gabapentin—epilepsy syndrome	3.26e-05	0.000835	CcSEcCtD
Fospropofol—Pruritus—Topiramate—epilepsy syndrome	3.09e-05	0.000793	CcSEcCtD
Fospropofol—Nausea—Gabapentin—epilepsy syndrome	3.09e-05	0.000792	CcSEcCtD
Fospropofol—Vomiting—Topiramate—epilepsy syndrome	2.78e-05	0.000713	CcSEcCtD
Fospropofol—Headache—Topiramate—epilepsy syndrome	2.74e-05	0.000703	CcSEcCtD
Fospropofol—Nausea—Topiramate—epilepsy syndrome	2.6e-05	0.000666	CcSEcCtD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC9A6—epilepsy syndrome	4.06e-06	8.17e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLCO1A2—epilepsy syndrome	4.06e-06	8.17e-05	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—PRKCB—epilepsy syndrome	4.05e-06	8.16e-05	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	4.04e-06	8.12e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	4.02e-06	8.1e-05	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—MTOR—epilepsy syndrome	4.02e-06	8.08e-05	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.96e-06	7.97e-05	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.96e-06	7.97e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	3.91e-06	7.86e-05	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—SLC6A1—epilepsy syndrome	3.9e-06	7.85e-05	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.9e-06	7.85e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	3.89e-06	7.82e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	3.89e-06	7.82e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC8A3—epilepsy syndrome	3.87e-06	7.79e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—GABRG2—epilepsy syndrome	3.87e-06	7.79e-05	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.86e-06	7.77e-05	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.85e-06	7.75e-05	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.84e-06	7.73e-05	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—PRKCB—epilepsy syndrome	3.84e-06	7.72e-05	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—PRKCB—epilepsy syndrome	3.79e-06	7.62e-05	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.78e-06	7.61e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	3.76e-06	7.56e-05	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—RELA—epilepsy syndrome	3.76e-06	7.56e-05	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.75e-06	7.55e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	3.73e-06	7.5e-05	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.72e-06	7.49e-05	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.71e-06	7.48e-05	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—CASP3—epilepsy syndrome	3.69e-06	7.43e-05	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.69e-06	7.43e-05	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.68e-06	7.41e-05	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.67e-06	7.38e-05	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.64e-06	7.32e-05	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.62e-06	7.29e-05	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.62e-06	7.28e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—PRKCB—epilepsy syndrome	3.61e-06	7.27e-05	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.6e-06	7.24e-05	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.59e-06	7.22e-05	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—JUN—epilepsy syndrome	3.59e-06	7.22e-05	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—CCL2—epilepsy syndrome	3.56e-06	7.16e-05	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.53e-06	7.11e-05	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.47e-06	6.98e-05	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—PRKCB—epilepsy syndrome	3.46e-06	6.97e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	3.46e-06	6.97e-05	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.42e-06	6.89e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	3.41e-06	6.87e-05	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL1B—epilepsy syndrome	3.4e-06	6.83e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—ADRA2A—epilepsy syndrome	3.38e-06	6.8e-05	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—PRKCB—epilepsy syndrome	3.37e-06	6.77e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CA13—epilepsy syndrome	3.31e-06	6.66e-05	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—PRKCB—epilepsy syndrome	3.31e-06	6.65e-05	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.28e-06	6.61e-05	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—PRKCB—epilepsy syndrome	3.25e-06	6.54e-05	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—PRKCB—epilepsy syndrome	3.23e-06	6.49e-05	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—SRC—epilepsy syndrome	3.22e-06	6.48e-05	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.19e-06	6.42e-05	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—PRKCB—epilepsy syndrome	3.17e-06	6.38e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	3.17e-06	6.37e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—APOD—epilepsy syndrome	3.16e-06	6.35e-05	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.13e-06	6.3e-05	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.13e-06	6.3e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	3.09e-06	6.21e-05	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.08e-06	6.19e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC1A1—epilepsy syndrome	3.08e-06	6.19e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC12A2—epilepsy syndrome	3.08e-06	6.19e-05	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.06e-06	6.16e-05	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3.06e-06	6.15e-05	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	3.04e-06	6.12e-05	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	3.03e-06	6.1e-05	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—TNF—epilepsy syndrome	3.03e-06	6.09e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TEK—epilepsy syndrome	3.02e-06	6.08e-05	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	3.02e-06	6.07e-05	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	3e-06	6.04e-05	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.99e-06	6.01e-05	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.99e-06	6.01e-05	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—RELA—epilepsy syndrome	2.98e-06	6e-05	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—IL1B—epilepsy syndrome	2.98e-06	6e-05	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—CASP3—epilepsy syndrome	2.97e-06	5.98e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—AKT3—epilepsy syndrome	2.96e-06	5.97e-05	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.94e-06	5.91e-05	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.94e-06	5.91e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	2.94e-06	5.91e-05	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.92e-06	5.87e-05	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—PTGS2—epilepsy syndrome	2.9e-06	5.83e-05	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.89e-06	5.82e-05	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—JUN—epilepsy syndrome	2.89e-06	5.81e-05	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.86e-06	5.76e-05	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.85e-06	5.74e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—FLNA—epilepsy syndrome	2.84e-06	5.72e-05	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.83e-06	5.69e-05	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—SLC2A1—epilepsy syndrome	2.82e-06	5.68e-05	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.82e-06	5.67e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	2.81e-06	5.66e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	2.81e-06	5.66e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	2.81e-06	5.66e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	2.81e-06	5.66e-05	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.79e-06	5.62e-05	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—PRKCB—epilepsy syndrome	2.77e-06	5.57e-05	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.74e-06	5.51e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—CDC42—epilepsy syndrome	2.71e-06	5.44e-05	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.7e-06	5.44e-05	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—IL1B—epilepsy syndrome	2.7e-06	5.43e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—KCNMA1—epilepsy syndrome	2.69e-06	5.42e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	2.66e-06	5.36e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SLC8A1—epilepsy syndrome	2.66e-06	5.35e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.62e-06	5.28e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	2.62e-06	5.26e-05	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.58e-06	5.18e-05	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.55e-06	5.14e-05	CbGpPWpGaD
Fospropofol—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—epilepsy syndrome	2.54e-06	5.11e-05	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—VEGFA—epilepsy syndrome	2.52e-06	5.08e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—L2HGDH—epilepsy syndrome	2.51e-06	5.05e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PDXK—epilepsy syndrome	2.51e-06	5.05e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—FAR1—epilepsy syndrome	2.51e-06	5.05e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ADK—epilepsy syndrome	2.51e-06	5.05e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GLUD1—epilepsy syndrome	2.51e-06	5.05e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CERS1—epilepsy syndrome	2.51e-06	5.05e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	2.5e-06	5.04e-05	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.5e-06	5.04e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.5e-06	5.02e-05	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.48e-06	4.99e-05	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.47e-06	4.98e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—VEGFA—epilepsy syndrome	2.47e-06	4.96e-05	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TNF—epilepsy syndrome	2.46e-06	4.96e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.46e-06	4.95e-05	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.46e-06	4.95e-05	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.44e-06	4.9e-05	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.42e-06	4.86e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—FYN—epilepsy syndrome	2.41e-06	4.85e-05	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.4e-06	4.83e-05	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.4e-06	4.83e-05	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.39e-06	4.82e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.39e-06	4.81e-05	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.38e-06	4.79e-05	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.36e-06	4.75e-05	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.36e-06	4.74e-05	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—epilepsy syndrome	2.35e-06	4.73e-05	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.34e-06	4.7e-05	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.32e-06	4.67e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—YWHAZ—epilepsy syndrome	2.31e-06	4.66e-05	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.3e-06	4.63e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.3e-06	4.63e-05	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—AVP—epilepsy syndrome	2.3e-06	4.63e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—EPM2A—epilepsy syndrome	2.29e-06	4.62e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GAMT—epilepsy syndrome	2.29e-06	4.62e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PNPO—epilepsy syndrome	2.29e-06	4.62e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NHLRC1—epilepsy syndrome	2.29e-06	4.62e-05	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	2.26e-06	4.55e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PPIA—epilepsy syndrome	2.24e-06	4.5e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.22e-06	4.48e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.22e-06	4.48e-05	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—TNF—epilepsy syndrome	2.16e-06	4.35e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CA4—epilepsy syndrome	2.13e-06	4.29e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—QDPR—epilepsy syndrome	2.13e-06	4.29e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	2.13e-06	4.29e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	2.06e-06	4.14e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ATP2A2—epilepsy syndrome	2.04e-06	4.11e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	2.04e-06	4.11e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—COX3—epilepsy syndrome	2.01e-06	4.04e-05	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—AKT1—epilepsy syndrome	2e-06	4.02e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.98e-06	3.99e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ITGA2—epilepsy syndrome	1.98e-06	3.99e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.98e-06	3.98e-05	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—TNF—epilepsy syndrome	1.96e-06	3.94e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—PRKCB—epilepsy syndrome	1.91e-06	3.84e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—KCNB1—epilepsy syndrome	1.9e-06	3.83e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLCO1A2—epilepsy syndrome	1.9e-06	3.83e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PFKL—epilepsy syndrome	1.9e-06	3.83e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CACNA2D2—epilepsy syndrome	1.9e-06	3.83e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC6A8—epilepsy syndrome	1.9e-06	3.83e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	1.86e-06	3.74e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.85e-06	3.72e-05	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.84e-06	3.7e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.81e-06	3.65e-05	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.81e-06	3.64e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.77e-06	3.56e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—ADRA2A—epilepsy syndrome	1.74e-06	3.51e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NEU1—epilepsy syndrome	1.74e-06	3.5e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—UPB1—epilepsy syndrome	1.74e-06	3.5e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ATIC—epilepsy syndrome	1.74e-06	3.5e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAT—epilepsy syndrome	1.74e-06	3.49e-05	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.71e-06	3.45e-05	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.69e-06	3.4e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HSD17B4—epilepsy syndrome	1.67e-06	3.37e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NOS1—epilepsy syndrome	1.63e-06	3.28e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPP1R3C—epilepsy syndrome	1.62e-06	3.25e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GBE1—epilepsy syndrome	1.62e-06	3.25e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	1.58e-06	3.18e-05	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.55e-06	3.11e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—AKT3—epilepsy syndrome	1.53e-06	3.08e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ASAH1—epilepsy syndrome	1.52e-06	3.06e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAUR—epilepsy syndrome	1.51e-06	3.04e-05	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.5e-06	3.02e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.5e-06	3.02e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—STXBP1—epilepsy syndrome	1.48e-06	2.98e-05	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.48e-06	2.97e-05	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.45e-06	2.92e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NT5E—epilepsy syndrome	1.44e-06	2.9e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ALAD—epilepsy syndrome	1.44e-06	2.9e-05	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.44e-06	2.9e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.43e-06	2.88e-05	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.41e-06	2.85e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CDC42—epilepsy syndrome	1.39e-06	2.81e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ALDH7A1—epilepsy syndrome	1.37e-06	2.77e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CACNA1A—epilepsy syndrome	1.37e-06	2.77e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ST3GAL3—epilepsy syndrome	1.35e-06	2.71e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ADSL—epilepsy syndrome	1.32e-06	2.65e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GLUL—epilepsy syndrome	1.29e-06	2.6e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CACNA1D—epilepsy syndrome	1.27e-06	2.55e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—FYN—epilepsy syndrome	1.24e-06	2.5e-05	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.24e-06	2.49e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—YWHAZ—epilepsy syndrome	1.19e-06	2.4e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TXNRD1—epilepsy syndrome	1.19e-06	2.39e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.18e-06	2.37e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.17e-06	2.35e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AQP1—epilepsy syndrome	1.15e-06	2.32e-05	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.13e-06	2.28e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SRC—epilepsy syndrome	1.12e-06	2.26e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	1.11e-06	2.23e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—VEGFA—epilepsy syndrome	1.09e-06	2.2e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAU—epilepsy syndrome	1.06e-06	2.13e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CHRM3—epilepsy syndrome	1.04e-06	2.1e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—KCNJ11—epilepsy syndrome	1.04e-06	2.1e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PRKCB—epilepsy syndrome	9.85e-07	1.98e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—NOS2—epilepsy syndrome	9.73e-07	1.96e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	9.7e-07	1.95e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	9.51e-07	1.91e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ABCG2—epilepsy syndrome	8.49e-07	1.71e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP2C19—epilepsy syndrome	8.28e-07	1.67e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP11A1—epilepsy syndrome	8.23e-07	1.66e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	8.17e-07	1.64e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP2D6—epilepsy syndrome	7.42e-07	1.49e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ADRA2A—epilepsy syndrome	7.07e-07	1.42e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—BCHE—epilepsy syndrome	7.04e-07	1.42e-05	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	6.98e-07	1.4e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC2A1—epilepsy syndrome	6.71e-07	1.35e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PLCB1—epilepsy syndrome	6.64e-07	1.34e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TH—epilepsy syndrome	6.62e-07	1.33e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	6.51e-07	1.31e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SRC—epilepsy syndrome	5.79e-07	1.16e-05	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—VEGFA—epilepsy syndrome	5.64e-07	1.13e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HMOX1—epilepsy syndrome	5.52e-07	1.11e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CAT—epilepsy syndrome	5.45e-07	1.1e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ABCB1—epilepsy syndrome	5.3e-07	1.07e-05	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GPX1—epilepsy syndrome	4.93e-07	9.92e-06	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AGT—epilepsy syndrome	4.32e-07	8.69e-06	CbGpPWpGaD
Fospropofol—ALB—Metabolism—APOE—epilepsy syndrome	4.23e-07	8.52e-06	CbGpPWpGaD
Fospropofol—ALB—Metabolism—POMC—epilepsy syndrome	3.64e-07	7.32e-06	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—AKT1—epilepsy syndrome	3.6e-07	7.24e-06	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTGS2—epilepsy syndrome	2.9e-07	5.84e-06	CbGpPWpGaD
Fospropofol—ALB—Metabolism—AKT1—epilepsy syndrome	1.46e-07	2.93e-06	CbGpPWpGaD
